1HM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Adaptive Biotechnologies Corp

Watchlist Manager

Watchlist

Price: 19.525 EUR Market Closed

Market Cap: €2.9B

A	Adaptive Biotechnologies Corp XMUN:1HM	US
	Xtant Medical Holdings Inc F:XMS	US
	Sitowise Group Oyj F:1FT	FI

Profitability Summary

Adaptive Biotechnologies Corp's profitability score is 23/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

75%

Strong 3Y Average Gross Margin

63%

Gross Margin is Increasing

64% > 75%

Negative Operating Margin

-16%

Negative 3Y Average Operating Margin

-77%

Operating Margin is Increasing

-100% > -16%

Negative Net Margin

-17%

Negative 3Y Average Net Margin

-81%

Net Margin is Increasing

-101% > -17%

Negative Free Cash Flow Margin

-10%

Negative 3Y Average Free Cash Flow Margin

-56%

Free Cash Flow Margin is Increasing

-89% > -10%

Negative ROE

-24%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-45%

ROIC is Increasing

-50% > -16%

View All

Hide

Collapse

23 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

75%

Strong 3Y Average Gross Margin

63%

Gross Margin is Increasing

64% > 75%

Negative Operating Margin

-16%

Negative 3Y Average Operating Margin

-77%

Operating Margin is Increasing

-100% > -16%